Does low free T4 during liothyronine use indicate limited thyroid reserve?

Clinical evidence and interpretation of low FT4

During liothyronine (T3) therapy, a decline in free T4 (FT4) levels is a predictable pharmacological response rather than an indicator of a depleted or limited native thyroid hormone reserve. Exogenous T3 suppresses thyroid-stimulating hormone (TSH) secretion via negative feedback, which subsequently downregulates endogenous T4 production by the thyroid gland. True glandular reserve is dictated by underlying pathology—such as autoimmune destruction or surgical ablation—and is independent of medication-induced lab patterns.

Mechanistic role of T4 as a prohormone

Circulating T4 acts as the essential prohormone substrate for local tissue activation. Approximately 80% of systemic T3 is generated peripherally through outer-ring deiodination of T4 by type 1 (D1) and type 2 (D2) deiodinases:

• D1 Deiodinase: Highly expressed in the liver and kidneys, where it generates T3 that rapidly enters the systemic circulation.
• D2 Deiodinase: Functions as an intracellular amplifier in tissues like the brain and skeletal muscle, converting T4 to T3 to maintain local cellular homeostasis independently of circulating T3 levels.

When exogenous T3 suppresses FT4, it depletes this critical circulating prohormone reservoir. Because liothyronine has a short half-life, standard formulations cause rapid peaks and troughs. The loss of a stable T4 substrate reservoir, combined with these fluctuations, can result in sub-therapeutic tissue-level thyroid exposure between doses, explaining why classical hypothyroid symptoms may persist despite therapy.

Bottom line

• Bottom line: While T4 is the critical prohormone substrate for tissue-level T3 conversion, a low free T4 level during liothyronine therapy is an expected pharmacological response to TSH suppression rather than a sign of limited thyroid reserve; however, the resulting depletion of the circulating T4 reservoir can lead to fluctuating tissue exposure and persistent hypothyroid symptoms.